IP Library Granted Patent US 12,070,581
Granted Patent B2
US 12,070,581 · App. 16/673,889 · Granted Aug 27, 2024

Injection system

Inventors: Gabrielle A. Rios (Newport Beach, CA); Clark B. Foster (Mission Viejo, CA)
Assignee: Truinject Corp.
A61M5/3129A61M5/3135A61M5/31511A61M5/31566A61M5/486G09B23/285A61M5/31568A61M5/427A61M2205/276A61M2205/3306A61M2205/332A61M2205/3331A61M2205/3375A61M2205/3389A61M2205/52A61M2205/581A61M2205/582A61M2205/583A61M2205/6009A61M2205/6054A61M2205/6072A61M2205/609A61M2210/0606
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,070,581
App. No.
16/673,889
Granted
Aug 27, 2024
Kind
B2
Abstract

A smart injection system that promotes patient safety includes, among other things, a smart stem that allows for measuring the location of the injection relative to the patient's face and/or the amount of medication injected into the patient. In addition, the smart stem has medication cartridge verification and injector verification features. The smart stem wirelessly transmits the measure data to a processing system.

Claims (25)

1. A method of automatically assessing accuracy in an injection procedure performed on a live patient, the method comprising:

providing an injection system comprising:

a syringe, wherein the syringe comprises a plunger, a syringe body, and a needle, the syringe configured to inject an injectable product directly into an anatomical location of the live patient at a predetermined target location, an efficacy or safety of the injectable product depending at least in part on an accuracy of an injection relative to the predetermined target location; and

one or more sensors coupled to the syringe, the one or more sensors configured to measure data indicative of a position and an orientation of the syringe relative to anatomy of the live patient;

receiving and analyzing, by a processor in communication with the one or more sensors, data of the injection from the one or more sensors; and

outputting a warning in response to detecting an error in the accuracy of the injection based at least in part on the data of the injection.

2. The method of claim 1 , further comprising determining the syringe is in an approved injection zone in the live patient.

3. The method of claim 2 , wherein the error comprises the syringe not being in the approved injection zone.

4. The method of claim 1 , wherein the error comprises comprise the syringe being in a no-injection zone in the live patient.

5. The method of claim 1 , wherein the injection system further comprises:

a plunger displacement sensor;

a force sensor; or

a pressure sensor.

6. The method of claim 5 , further comprising detecting that a volume of the injectable product injected into the live patient is inaccurate based at least in part on data from the plunger displacement sensor.

7. The method of claim 5 , further comprising detecting that a rate of injection of the injectable product or an injection force exceeds a threshold based at least in part on data from the plunger displacement sensor, the force sensor, or the pressure sensor.

8. The method of claim 5 , further comprising detecting that the needle is in an artery of the live patient based at least in part on data from:

the plunger displacement sensor; and

the force sensor or the pressure sensor.

9. The method of claim 8 , wherein the needle being in the artery is detected by the processor determining a relationship of a measured injection force or pressure and a measured rate of plunger displacement, wherein the processor is configured to analyze an injectable product flow rate calculated from the measured rate of plunger displacement when the measured injection force or pressure is within a range.

10. The method of claim 9 , further comprising outputting a second warning instructing an injector to stop the injection immediately and apply an occlusion dissolving agent.

11. The method of claim 10 , wherein the dissolving agent comprises hyaluronidase.

12. The method of claim 10 , wherein the second warning allows the injector to replace the syringe body containing the injectable product with another syringe body containing the occlusion dissolving agent when the needle is inside the artery.

13. The method of claim 1 , wherein the warning comprises audio, visual, or tactile feedback, or any combinations thereof.

14. The method of claim 1 , wherein the one or more sensors comprise an inertia motion sensor.

15. The method of claim 14 , further comprising comparing data from the inertia motion sensor with anatomical landmarks information preloaded on the processor to calculate the position and the orientation of the syringe relative to the anatomy of the live patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2024
From: RIOS, GABRIELLE A.; FOSTER, CLARK B.
To: TRUINJECT MEDICAL CORP.
Reel/Frame 068012/0034 →
CHANGE OF NAME Recorded Jul 17, 2024
From: TRUINJECT MEDICAL CORP.
To: TRUINJECT CORP.
Reel/Frame 068420/0216 →
Continuity (3)
Continuation 15299209 · Oct 20, 2016
Provisional Application 62243801 · Oct 20, 2015
Related Publication 20200206424A1 · Jul 2, 2020
Cited By (3)
US 12,350,472 US 12,456,393 US 12,562,078